Guardant Health (NASDAQ: GH) reported Q1 EPS of ($0.49), $0.26 better than the analyst estimate of ($0.75). Revenue for the quarter came in at $203.5 million versus the consensus estimate of $190.01 million.

GUIDANCE:

Guardant Health sees FY2025 revenue of $880-890 million, versus the consensus of $857.7 million.

For earnings history and earnings-related data on Guardant Health (GH) click here.